Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T05:49:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice was added, noting possible delays and directing readers to cc.nih.gov and opm.gov for status updates. The page revision changed from v3.4.0 to v3.4.1 and added related topics such as Type 2 diabetes and MedlinePlus Genetics.
    Difference
    0.4%
    Check dated 2026-02-04T04:31:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata fields to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a revision note 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or updated accordingly.
    Difference
    0.1%
    Check dated 2026-01-28T02:38:34.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page no longer lists the condition 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics'. This reduces the explicit tagging of the study's focus and related resources on the page.
    Difference
    0.1%
    Check dated 2026-01-21T00:31:19.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to core study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:44:30.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The Locations section was reorganized to add a top-level Locations header and individual province/municipality subsections (Anhui, Beijing Municipality, Chongqing Municipality, etc.), replacing the previous per-location headers.
    Difference
    2%
    Check dated 2025-12-23T12:47:15.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.